Rehydration is essential in managing HHS to improve tissue perfusion, correct dehydration, and restore fluid balance
Targeting enteric release of therapeutic peptides by encapsulation in complex coacervated matrix microparticles by spray drying
Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss
To make the decision process immediately clear, here is a simple decision table based on your primary area of study
JCI Insight 8 , e165709 (2023)

NICEs quality standard on maintaining weight after GLP-1 treatment Advice for maintaining changes and support for improving their health and wellbeing Ensuring that people stopping medicines for weight management or leaving behavioural weight management services after completing a behavioural overweight and obesity management intervention: receive feedback and monitoring at regular intervals for a minimum of 1 year so they can get help if they are not maintaining changes have well-rehearsed action plans (such as ifthen plans) that they can easily put into practice if they are not maintaining changes have thought about how they can make changes to their own immediate physical environment to prevent weight regain have the social support they need to maintain changes are helped to develop routines that support the new behaviour (note that small, manageable changes to daily routine are most likely to be maintained) are offered a range of options for follow-up sessions after an intervention active phase has been completed, including at different times and in easily accessible and suitable venues
